Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
In the Triangle, office vacancies are at record highs. Some buildings, like Roxboro at Venable Center in Durham, are sitting ...
In the face of employee backlash over JPMorgan Chase’s 5-day-a-week return to work mandate, company leaders are hoping their ...
A new tower is rising in Fort Greene, and it might just win over audiophiles. In October 2023, developer Charney Companies ...
JPMorgan Chase’s new headquarters in Manhattan is designed to make the 5-day return-to-office mandate more enticing, with ...